Alkermes' narcolepsy drug meets main goal in a mid-stage trial
Nov 12 (Reuters) - Alkermes ALKS.O said on Wednesday its experimental narcolepsy drug met the main goals in a mid-stage study. (Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva) ((Kamal.Choudhury@thomsonreuters.com;))